Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.

cardiovascular disease cirrhosis clinical research/practice complication: medical/metabolic diagnostic techniques and imaging: echocardiography liver transplantation/hepatology translational research/science

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
06 2021
Historique:
revised: 04 01 2021
received: 19 10 2020
accepted: 07 01 2021
pubmed: 17 1 2021
medline: 29 6 2021
entrez: 16 1 2021
Statut: ppublish

Résumé

It is postulated that cardiac structural abnormalities observed in cirrhotic cardiomyopathy (CCM) contribute to the electrophysiologic abnormality of QT interval (QTc) prolongation. We sought to evaluate whether QTc prolongation is associated with intrinsic abnormalities in cardiac structure and function that characterize CCM. Consecutive patients undergoing liver transplant work-up between 2010 and 2018 were included. Measures of cardiac function on stress testing including cardiac reserve and chronotropic incompetence were collected prospectively and a corrected QTc ≥ 440 ms was considered prolonged. Overall, 439 patients were included and 65.1% had a prolonged QTc. There were no differences in markers of left ventricular and atrial remodeling, or resting systolic and diastolic function across QTc groups. The proportion of patients that met the criteria for a low cardiac reserve (39.2 vs 36.6%, p = .66) or chronotropic incompetence (18.1 vs 21.3%, p = .52) was not different in those with a QTc ≥ 440 vs <440 ms. Further, there was no association between QTc prolongation and CCM by either the 2005 World College of Gastroenterology or modified 2020 Cirrhotic Cardiomyopathy Consortium criteria. QT interval prolongation was not associated with structural or functional cardiac abnormalities that characterize CCM. These findings suggest that CCM and QT interval prolongation in cirrhosis may be two separate entities with distinct pathophysiological origins.

Identifiants

pubmed: 33453141
doi: 10.1111/ajt.16500
pmc: PMC8819736
mid: NIHMS1775407
pii: S1600-6135(22)08598-7
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2240-2245

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL136891
Pays : United States

Informations de copyright

© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

Gut. 2008 Feb;57(2):268-78
pubmed: 18192456
Hepatology. 2018 Nov;68(5):2008-2015
pubmed: 29672903
Transplantation. 2021 Mar 1;105(3):593-601
pubmed: 32413014
Gastroenterology. 2001 Nov;121(5):1209-18
pubmed: 11677214
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):177-86
pubmed: 24217347
Clin Transplant. 2016 Sep;30(9):986-93
pubmed: 27292629
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
Eur Heart J Qual Care Clin Outcomes. 2020 Oct 1;6(4):243-253
pubmed: 32011663
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Am J Transplant. 2021 Feb;21(2):593-603
pubmed: 32530547
Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):329-37
pubmed: 16741552
Hepatology. 1998 Jan;27(1):28-34
pubmed: 9425913
Liver Transpl. 2013 Jul;19(7):701-10
pubmed: 23554120
J Card Fail. 2019 Mar;25(3):166-172
pubmed: 30412734
Am J Physiol. 1997 Aug;273(2 Pt 1):G537-44
pubmed: 9277435
Liver Transpl. 2014 Nov;20(11):1306-16
pubmed: 25044256
Gut. 2001 Aug;49(2):268-75
pubmed: 11454805
Hepatology. 2020 May;71(5):1883
pubmed: 31709570
Transplantation. 2012 Sep 27;94(6):646-51
pubmed: 22918216
Hepatology. 2020 Jan;71(1):334-345
pubmed: 31342529
Hepatol Int. 2009 Mar;3(1):294-304
pubmed: 19669380
J Cardiovasc Electrophysiol. 2007 Jan;18(1):77-82
pubmed: 17229304
Int J Cardiol. 2021 Mar 1;326:158-163
pubmed: 33186663
Hepatology. 1996 May;23(5):1128-34
pubmed: 8621144
J Hepatol. 1995 Mar;22(3):326-32
pubmed: 7608484
Am J Gastroenterol. 2020 Mar;115(3):388-397
pubmed: 31738284
J Hepatol. 1997 Apr;26(4):904-12
pubmed: 9126806
Liver Int. 2003 Aug;23(4):243-8
pubmed: 12895263

Auteurs

Anoop N Koshy (AN)

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Parkville, Victoria, Australia.

Paul J Gow (PJ)

The University of Melbourne, Parkville, Victoria, Australia.
Victorian Liver Transplant Unit, Austin Hospital, Melbourne, Victoria, Australia.

Adam Testro (A)

The University of Melbourne, Parkville, Victoria, Australia.
Victorian Liver Transplant Unit, Austin Hospital, Melbourne, Victoria, Australia.

Andrew W Teh (AW)

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Parkville, Victoria, Australia.

Jefferson Ko (J)

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.

Han S Lim (HS)

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Parkville, Victoria, Australia.

Hui-Chen Han (HC)

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Parkville, Victoria, Australia.

Laurence Weinberg (L)

The University of Melbourne, Parkville, Victoria, Australia.
Department of Anaesthesia, Austin Health, Melbourne, Victoria, Australia.

Lisa B VanWagner (LB)

Division of Gastroenterology & Hepatology and Preventive Medicine-Epidemiology Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Omar Farouque (O)

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH